• Mutation; HGNC; 6407; KRAS; Simple; p.Gly10_Ala11insGly (c.31_32insGAG); Zygosity=Unspecified (DepMap=ACH-000084).
  

PubMed=8667638
Hu Z.-B., Ma W., Zaborski M., MacLeod R.A.F., Quentmeier H., Drexler H.G.
Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
Leukemia 10:1025-1040(1996)

PubMed=9096695; DOI=10.1038/sj.leu.2400621
Drexler H.G., Zaborski M., Quentmeier H.
Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
Leukemia 11:541-551(1997)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=12091369; DOI=10.1182/blood.V100.2.701
Masterson A.J., Sombroek C.C., de Gruijl T.D., Graus Y.M.F., van der Vliet H.J.J., Lougheed S.M., van den Eertwegh A.J.M., Pinedo H.M., Scheper R.J.
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors.
Blood 100:701-703(2002)

PubMed=16408098; DOI=10.1038/sj.leu.2404081
Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
Leukemia 20:471-476(2006)

PubMed=16423051; DOI=10.1111/j.1365-2567.2005.02274.x; PMCID=PMC1782214
Larsson K., Lindstedt M., Borrebaeck C.A.K.
Functional and transcriptional profiling of MUTZ-3, a myeloid cell line acting as a model for dendritic cells.
Immunology 117:156-166(2006)

PubMed=17533051; DOI=10.1016/j.exphem.2007.03.003
Ciraci E., Barisani D., Parafioriti A., Formisano G., Arancia G., Bottazzo G.F., Berardi A.C.
CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts.
Exp. Hematol. 35:967-977(2007)

Patent=US9029143
Goletz S., Scheper R.J., Masterson A.J., Pinedo H.M.
MUTZ-3 dendritic cells.
Patent number US9029143, 15-May-2015

PubMed=26252775; DOI=10.1371/journal.pone.0135219; PMCID=PMC4529224
Ruben J.M., Visser L.L., Heinhuis K.M., O'Toole T., Bontkes H.J., Westers T.M., Ossenkoppele G.J., de Gruijl T.D., van de Loosdrecht A.A.
A human cell line model for interferon-alpha driven dendritic cell differentiation.
PLoS ONE 10:E0135219-E0135219(2015)

PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878
Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P., Loewer M., Sahin U., Castle J.C.
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
Genome Med. 7:118.1-118.7(2015)

PubMed=26764012; DOI=10.1074/mcp.M115.055780; PMCID=PMC4824864
Mommen G.P.M., Marino F., Meiring H.D., Poelen M.C.M., van Gaans-van den Brink J.A.M., Mohammed S., Heck A.J.R., van Els C.A.C.M.
Sampling from the proteome to the human leukocyte antigen-DR (HLA-DR) ligandome proceeds via high specificity.
Mol. Cell. Proteomics 15:1412-1423(2016)

PubMed=30285677; DOI=10.1186/s12885-018-4840-5; PMCID=PMC6167786
Tan K.-T., Ding L.-W., Sun Q.-Y., Lao Z.-T., Chien W., Ren X., Xiao J.-F., Loh X.-Y., Xu L., Lill M., Mayakonda A., Lin D.-C., Yang H.H., Koeffler H.P.
Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.
BMC Cancer 18:940.1-940.13(2018)

PubMed=30629668; DOI=10.1371/journal.pone.0210404; PMCID=PMC6328144
Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.
Screening human cell lines for viral infections applying RNA-Seq data analysis.
PLoS ONE 14:E0210404-E0210404(2019)

PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103
Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. 3rd, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature 569:503-508(2019)

PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646
Quentmeier H., Pommerenke C., Dirks W.G., Eberth S., Koeppel M., MacLeod R.A.F., Nagel S., Steube K.G., Uphoff C.C., Drexler H.G.
The LL-100 panel: 100 cell lines for blood cancer studies.
Sci. Rep. 9:8218-8218(2019)